December 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreDecember 26, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreDecember 26, 2025
The anti-aging market size is forecast to grow from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 15, 2026
According to forecasts, the global endocrine testing market will grow from USD 3.25 billion in 2025 to USD 7.36 billion by 2034, with an expected CAGR of 8.54%. With more individuals proactively monitoring their health, the endocrine testing market is seeing a growing interest in personalized medicine and home-based testing kits. North America led ...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, val...
January 09, 2026
Projections indicate that, the global bilirubin blood test market will increase from USD 1.38 billion in 2025 to USD 2.62 billion by 2035, experiencing a CAGR of 6.67% over the next 10 years.The market is expanding due to the rising prevalence of liver diseases and neonatal jaundice, necessitating early and accurate diagnosis. Additionally, advance...
January 08, 2026
According to market projections, the mental health tester market was valued at USD 1.78 billion in 2026 and is projected to reach USD 3.43 billion by 2035, expanding at a CAGR of 7.54% from 2026 to 2035. The mental health tester market report provides comprehensive insights into product type, application, end-user, and technology segments....
January 07, 2026
According to forecasts, the U.S. liquid biopsy market was valued at USD 2.44 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to USD 8.90 billion by 2035, registering a CAGR of 13.82% (2026–2035). The U.S. liquid biopsy market report provides detailed analysis of market size, growth trends, and forecast statistics, along...
January 06, 2026
According to market projections, the global novel spectrometry market, valued at USD 4.18 billion in 2025, is anticipated to reach USD 23.35 billion by 2035, growing at a CAGR of 18.77% over the next decade. Advancements in technology and growing research and development activities drive the market. North America dominated the global market due to ...
January 05, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&D for new treatments and diagnoses....
January 02, 2026
Market insights predict, the U.S. Tuberculosis (TB) Diagnostics Market was valued at USD 650.8 million in 2025 and is projected to reach USD 687.51 million in 2026, further expanding to USD 1,126.5 million by 2035 at a CAGR of 5.64% (2026–2035). This report provides in-depth coverage of market size, growth trends, test type, disease type...
January 02, 2026
Market insights predict the global magnetic resonance imaging (MRI) industry will increase from USD 7.54 billion in 2025 to USD 14.18 billion by 2035, achieving a CAGR of 6.52%. It is anticipated that rising disease prevalence will have a significant impact on market expansion....
December 30, 2025
According to market projections, the global lateral flow assays market, valued at USD 12.76 billion in 2025, is anticipated to reach USD 27.40 billion by 2035, growing at a CAGR of 7.94% over the next decade. The lateral flow assays market is expanding due to growing demand for point-of-care testing as well as growing development of multiplex and...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com